NALMEFENE HCL
Live / Applied — New application — not yet assigned to an examiner (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 18 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99710822
- Mark type
- Design + words
- Filed
- 18 Mar 2026
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Owner
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 18 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 18 Mar 2026 — NEW APPLICATION ENTERED